| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/29/2008 | WO2008061377A1 Novel receptor for cd40l and uses thereof |
| 05/29/2008 | WO2008040649A3 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2007130353A3 Phase 2 inducers, ppar-alpha agonists and related signalling pathways protect cartilage against inflammation, apoptosis and stress |
| 05/29/2008 | WO2007106884A3 Methods of treating muscular wasting diseases using nf-kb activation inhibitors |
| 05/29/2008 | WO2007103468A3 Use of vx-702 for treating rheumatoid arthritis |
| 05/29/2008 | WO2007074456A3 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 05/29/2008 | US20080125484 Synthetic Lactone Formulations and Methods of Use |
| 05/29/2008 | US20080125474 Pyrazole Analogs |
| 05/29/2008 | US20080125460 inducible nitric oxide synthase inhibitors; acute or chronic inflammatory diseases of of peripheral organs and the central nervous system; 6-pyridinyl imidazo-[4,5-b]pyridine compounds; 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-(pyridin-4-yl)-3H-imidazo-[4,5-b]pyridine |
| 05/29/2008 | US20080125446 For example, 6-amino-2-(chloro or fluoro)-8-(arylthio(oxo))-9H-purines; complex with Heat Shock Protein 90 (HSP 90); proliferative disorders such as breast cancer |
| 05/29/2008 | US20080125426 7-(4-Chlorophenyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; reversible inhibitors of cysteine proteases S, K, F, L, B; diseases associated with Cathepsin S; antiinflammatory agent, autoimmune diseases; asthma, rheumatoid arthritis, multiple sclerosis, Alzheimer's and Crohn's disease |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125417 4-Tert-Butyl-N-(2-methyl-3-{2-[4-(morpholine-4-carbonyl)-phenylamino]-pyrimidin-4-yl}-phenyl)-benzamide;enzyme inhibitors of Burton's tyrosine kinase (Btk); autoimmune diseases; antiinflammatory/-arthritic agents; X-linked agammaglobulinaemia; antiallergens; osteoporosis; determining the presence Btk |
| 05/29/2008 | US20080125355 Endogenous Peptide and Active Subfragments Thereof |
| 05/29/2008 | US20080125346 Infant Formula |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124413 Novel composition containing extracts of butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation hypersensitivity or pain |
| 05/29/2008 | US20080124393 Time-release agent containing poorly soluble agent such as clozapine; release the agent following administration for a time period ranging from about 2 to about 24 hours or longer |
| 05/29/2008 | US20080124386 Apoptosis-mimicking synthetic entities and use thereof in medical treatment |
| 05/29/2008 | US20080124377 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 05/29/2008 | US20080124358 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 05/29/2008 | US20080124346 Chimeric metal binding protein for use in prevention and treatment of cancer, diabetes, cardiovascular disease, obesity, metabolic disease, neurodegenerative disease, gastrointestinal disease, autoimmune disease, rheumatological disease and infectious disease. |
| 05/29/2008 | US20080124319 Using immunoglobulin agonist to prevent signaling from g protein coupled receptor/melanin concentrating hormone receptor and treat gastrointestinal disorders |
| 05/29/2008 | DE102006056458A1 Arzneimittelzubereitung von Tramadol und Acetaminophen The pharmaceutical preparation of tramadol and acetaminophen |
| 05/29/2008 | CA2679955A1 Novel chemotherapeutic agents against inflammation and cancer |
| 05/29/2008 | CA2677335A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 05/29/2008 | CA2670288A1 Methods of treating chronic inflammatory diseases using a gm-csf antagonist |
| 05/29/2008 | CA2670202A1 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists |
| 05/29/2008 | CA2670044A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | CA2670042A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | CA2670031A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | CA2670026A1 Heterotricyclic metalloprotease inhibitors |
| 05/29/2008 | CA2669579A1 5-sulfanylmethyl-pyrazolo [1,5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists |
| 05/29/2008 | CA2668652A1 Inhibitors of voltage-gated ion channels for use in treating pain and pruritis |
| 05/29/2008 | CA2666224A1 Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
| 05/28/2008 | EP1925299A1 Adhesive patch less irritative to skin |
| 05/28/2008 | EP1924605A1 Compositions and methods for diagnosing and treating an inflammation |
| 05/28/2008 | EP1924584A1 Use of fused imidazole derivatives to mediate ccr3 related conditions |
| 05/28/2008 | EP1924580A1 Non-steroidal compounds useful as glucocorticoid receptor modulators |
| 05/28/2008 | EP1924553A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
| 05/28/2008 | EP1924274A1 Modulation of cell fates and activities by phthalazinediones |
| 05/28/2008 | EP1701940B1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 05/28/2008 | EP1605946B1 Thiazoles useful as inhibitors of protein kinases |
| 05/28/2008 | EP1501507B1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1471895B1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| 05/28/2008 | EP1424329B1 Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1404864A4 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 05/28/2008 | EP1399744B1 Epf receptor assays, compounds and therapeutic compositions |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1326630B1 Use of glp-2 peptides |
| 05/28/2008 | EP1246925B1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 05/28/2008 | EP1066315B1 Use of inhibitors of mammalian asparaginyl endopeptidase for modulating the immune system |
| 05/28/2008 | CN101189016A Device and methods for treating paranasal sinus conditions |
| 05/28/2008 | CN101186632A Method for preparing eleutheroside or aglycone thereof with anti-inflammatory action |
| 05/28/2008 | CN101186612A Pyrroline derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN101186611A Pyrroline-2-one derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN101186583A Methyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate and its synthesizing method and application |
| 05/28/2008 | CN101186580A Gaba analogs and its medical compositions |
| 05/28/2008 | CN101185868A Technique for preparing lomoxicam ultra-fine particles using by supercritical fluid crystallization technology |
| 05/28/2008 | CN101185745A Hyperosteogeny ache eliminating liquid |
| 05/28/2008 | CN101185732A Rheumatism preparation preparing method |
| 05/28/2008 | CN101185713A Medicine preparation for treating traumatic injuries and its preparation method and quality control method |
| 05/28/2008 | CN101185692A Nauclea officinalis extract and preparation and use thereof |
| 05/28/2008 | CN101185681A Medicinal composition for treating rheumatoid arthritis and preparation method and application |
| 05/28/2008 | CN101185667A Orally-administered medicine wine for treating lumbar sprain |
| 05/28/2008 | CN101185663A Method for obtaining the extraction from caper medicinal part and application of the extraction |
| 05/28/2008 | CN101185640A Lomoxicam sustained release tablet and preparation method thereof |
| 05/28/2008 | CN101185636A Oridonin injection and power injection containing sulfobutyl ether beta-cyclodextrin and preparation method thereof |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390163C 2-(2,6-dioxopiperidin-3-yl)-isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390155C Quinoline and quinoxaline compounds |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/28/2008 | CN100390131C Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 05/28/2008 | CN100389821C Stabilized liquid polypeptide-containing pharmaceutical composition |
| 05/28/2008 | CN100389820C Therapeutic agent comprising botulinum neurotoxin |
| 05/28/2008 | CN100389811C Wind dispelling drop pill containing amomum fruit |
| 05/28/2008 | CN100389800C Medicinal preparation for treating cold abscess and all kinds of body surface ulcer |
| 05/28/2008 | CN100389788C Extract of perilla and its use in preparation of medicine |
| 05/28/2008 | CN100389786C Wind arthralgia treating wine and manufacturing method thereof |
| 05/28/2008 | CN100389783C Extraction process of effective Chuanxiong component |
| 05/28/2008 | CN100389753C Oral drop pills with heat-clearing and detoxification function |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378525 CCR8 inhibitors |
| 05/27/2008 | US7378444 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 05/27/2008 | US7378436 Substituted N-[pyrrolidin-3-yl] benzamides or naphthamides; serotonin and noradrenaline receptor antagonists; urinary incontinence; arylation of the amino pyrrolidine with a carboxylic acid or acyl halide and then deprotecting |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378416 3-((C3-8)cycloalkyl)-3,4-dihydro-benzo[e][1,3]oxazin-2-ones; counter-regulator of antiinflammatory effects of glucocorticoids with effect that normal activities of glucocorticoids to limit and suppress severity of inflammatory responses are inhibited by macriphage migration inhibitory factor (MIF) |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
| 05/27/2008 | US7378102 Diclofenac sodium oral pharmaceutical |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/27/2008 | CA2345064C Fentanyl composition for the treatment of acute pain |
| 05/22/2008 | WO2008061006A1 Substituted indan-2-yl, tetrahydronaphthalen-2-yl, or dihydr0-2h-chr0men-3-yl arylsulfonamides and methods of their use |
| 05/22/2008 | WO2008060771A2 Pyrazole compounds |
| 05/22/2008 | WO2008060764A2 Topical therapies for oral mucositis and other conditions |